 |
|
Age-Related Distribution of Neuropathologic Changes in the Cerebral Cortex of Patients With Down's SyndromeQuantitative Regional Analysis and Comparison With Alzheimer's Disease
Patrick R. Hof, MD;
Constantin Bouras, MD;
Daniel P. Perl, MD;
D. Larry Sparks, PhD;
Nehal Mehta;
John H. Morrison, PhD
Arch Neurol. 1995;52(4):379-391.
Abstract
| |
Objective
To investigate whether changes in the cerebral cortex exhibit similar distribution patterns in both disorders of Down's syndrome and Alzheimer's disease, we performed a comparative neuropathologic study of patients with these disorders to further clarify the possible relationships between these dementing conditions.
Design
The regional and laminar distribution and density of neurofibrillary tangles and senile plaques were analyzed in the cerebral cortex of a series of 16 patients (aged 6 to 74 years) with Down's syndrome and in 10 elderly individuals with Alzheimer's disease.
Results
Quantitative analyses revealed that the time course of neurofibrillary tangle formation in Down's syndrome displays regional patterns comparable with those observed in aging and Alzheimer's disease with layer II of the entorhinal cortex being affected first in Down's syndrome, followed by the hippocampus proper and neocortex. The oldest patients with Down's syndrome had neurofibrillary tangle densities sometimes higher than in patients with Alzheimer's disease. At variance with Alzheimer's disease, amyloid deposition was widespread in all of the cortical areas investigated and was observed much earlier than neurofibrillary tangle formation. Patients with Down's syndrome also frequently had higher senile plaque densities than patients with Alzheimer's dis
Conclusions
These results indicate that the development of pathologic changes in patients with Down's syndrome does not parallel that observed in elderly individuals and patients with Alzheimer's disease in all respects. However, the comparable development patterns of neurofibrillary tangle formation suggest that detailed analysis of patients with Down's syndrome may be useful to further our knowledge of the mechanisms underlying the installation of the neuropathologic alterations leading to the demonstrated loss of select neuronal populations in Alzheimer's disease.
Author Affiliations
From the Fishberg Research Center for Neurobiology (Drs Hof, Bouras, Perl, and Morrison and Mr Mehta), the Departments of Geriatrics and Adult Development (Drs Hof and Morrison), Pathology (Neuropathology), and Psychiatry (Dr Perl), Mount Sinai School of Medicine, New York, NY; the Alzheimer's Disease Research Center/Sanders-Brown Center on Aging, the Departments of Pathology and Neurology, University of Kentucky Medical Center, and the Kentucky Medical Examiner's Program, Justice Cabinet, Lexington (Dr Sparks); and the Department of Psychiatry, IUPG Bel-Air, University of Geneva (Switzerland) School of Medicine (Dr Bouras).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry
Teipel et al.
Brain 2004;127:811-824.
ABSTRACT
| FULL TEXT
Quantitative Analysis of Retinal Ganglion Cell (RGC) Loss in Aging DBA/2NNia Glaucomatous Mice: Comparison with RGC Loss in Aging C57/BL6 Mice
Danias et al.
IOVS 2003;44:5151-5162.
ABSTRACT
| FULL TEXT
Relation of Corpus Callosum and Hippocampal Size to Age in Nondemented Adults With Down's Syndrome
Teipel et al.
Am. J. Psychiatry 2003;160:1870-1878.
ABSTRACT
| FULL TEXT
Relation of Medial Temporal Lobe Volumes to Age and Memory Function in Nondemented Adults With Down's Syndrome: Implications for the Prodromal Phase of Alzheimer's Disease
Krasuski et al.
Am. J. Psychiatry 2002;159:74-81.
ABSTRACT
| FULL TEXT
High Brain myo-Inositol Levels in the Predementia Phase of Alzheimer’s Disease in Adults With Down’s Syndrome: A 1H MRS Study
Huang et al.
Am. J. Psychiatry 1999;156:1879-1886.
ABSTRACT
| FULL TEXT
New Neuropathological Criteria for Alzheimer Disease
Hyman
Arch Neurol 1998;55:1174-1176.
FULL TEXT
Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer''s Disease
Gomez-Isla et al.
J. Neurosci. 1996;16:4491-4500.
ABSTRACT
| FULL TEXT
Neuropathological Changes in Down's Syndrome Hippocampal Formation: Effect of Age and Apolipoprotein E Genotype
Hyman et al.
Arch Neurol 1995;52:373-378.
ABSTRACT
|
